Results 161 to 170 of about 173,430 (355)
A YAP/TAZ–CDC6 Axis Initiates and Maintains Malignant Transformation
This study demonstrates that constitutive activation of YAP or TAZ is sufficient to induce and maintain malignant transformation in fibroblasts, identifying them as essential oncogenic drivers. Transcriptomic and functional analyses revealed CDC6 as a critical downstream effector of YAP/TAZ, with elevated expression linked to tumorigenesis across ...
David Nduru +5 more
wiley +1 more source
Paediatric soft tissue sarcomas in a resource constrain setting: Grade and stage at presentation and at oncologic intervention are usually of poor prognostic characteristics. [PDF]
Gabriel Olabiyi Ogun +6 more
openalex +1 more source
This study investigates genotype–phenotype correlations in Japanese families with germline TP53 pathogenic variants, collected through a nationwide prospective cancer surveillance study (JCCG LFS‐20). Among 41 families analyzed, 36 met criteria for Li–Fraumeni syndrome (LFS), and 5 were classified as attenuated LFS.
Fumito Yamazaki +14 more
wiley +1 more source
Evaluating referral patterns and treatment timeliness for soft tissue sarcoma in rural
Ellen Maclean +4 more
openalex +1 more source
Liquid–Liquid Phase Separation in Major Hallmarks of Cancer
Aberrant condensates formed through phase separation are involved in the dysregulation of various critical cellular processes, including genome stability, transcriptional regulation and signal transduction, thereby promoting malignant transformation and the acquisition of multiple cancer hallmarks.
Chen‐chen Xie +10 more
wiley +1 more source
The greatest achievements in oncology in 2022 – melanoma and skin carcinomas
Piotr Rutkowski
doaj +1 more source
Atypical Fibroxanthoma/Pleomorphic Dermal Sarcoma With Osseous Metaplasia: A Series of Three Cases
ABSTRACT Atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS) are rare mesenchymal tumors typically arising on sun‐damaged skin of the head and neck in elderly patients. PDS is a more aggressive tumor but with similar demographics, cellular morphology, immunohistochemical features, and genetic findings.
Taylor Novice +3 more
wiley +1 more source
Summary Defensive medicine refers to diagnostic or therapeutic actions taken primarily to reduce legal liability rather than to benefit the patient. In dermatopathology, defensive practices manifest in frequent immunohistochemical testing, overly cautious report phrasing, and reliance on multidisciplinary tumor boards.
Cornelia Sigrid Lissi Müller +2 more
wiley +1 more source
Intra- and inter-observer agreement in histological assessment of canine soft tissue sarcoma [PDF]
Antonescu +21 more
core +2 more sources

